StopDown
Temple logo
Company

Temple

Brain-health wearable makertemple.com ↗LinkedIn ↗X ↗Instagram ↗

Temple revenue, valuation and funding

Its latest reported valuation is $190M, as reported by StopDown on 6 November 2026. It has raised $54M in total, as reported by StopDown on 6 November 2026.

Temple revenue, valuation and funding
Valuation$190M
Total raised$54M

Each figure links to the story that reported it.

Temple key facts

$54 millionSeed round, Feb 2026about $190M post-money
$375 millionValuation, Jul 2026after ESOP secondary sale

Funding rounds

Temple funding rounds, as announced
WhenRoundAmountInvestorsSource
Feb 2026Seed$54 million (₹493 crore)Deepinder Goyal (Rs 104 crore, largest), Steadview Capital, Peak XV Partners, Dharana Capital, Info Edge, Nikhil Kamath, Kunal Shah, Vijay Shekhar Sharma, dozens of other investors, including employees EntrackrEntrackr

Timeline

  • 2026
  • Feb 2026 Raises $54 million at about $190 million post-money EntrackrEntrackr
  • May 2026 Zetwerk and Ethereal Machines reported as manufacturing partners Inc42
  • Jul 2026 Valuation reportedly doubles to $375 million in ESOP-linked secondary sale Entrackr
  • Aug 2026 Acquires London clinic Longevous Entrackr
  • Sep 2026 Publishes first validation study Inc42
  • Sep 2026 Research tie-up with Art of Living's SSIAR on meditation Indian Startup News
  • Nov 2026 Pre-orders open Moneycontrol
  • Nov 2026 Doctors questioned the wearable's brain-flow claims; Goyal called it a fitness gadget Business Standard

The short version

  • Temple is a wearable startup founded by Deepinder Goyal, the Zomato founder. The device sits on the side of the forehead and tracks signals linked to blood flow in the brain. EntrackrMoneycontrol
  • It shows a score called Entropy on a scale of 1 to 250, which the company says reflects how hard the body is working. Temple says it is sold for general wellness, not diagnosis. EntrackrIndian Startup News
  • In February 2026 it raised $54 million (₹493 crore) at about $190 million post-money. Goyal put in about ₹104 crore, with Steadview Capital, Peak XV Partners, Dharana Capital and Info Edge among the investors. EntrackrEntrackr
  • In July 2026 the valuation reportedly doubled to $375 million through a secondary sale linked to its first ESOP liquidity programme. Entrackr
  • In August 2026 it bought London longevity clinic Longevous for an undisclosed sum; co-founders Robert Mohr and Avi Roy joined as Chief Medical Officer and Head of Science. Entrackr
  • A first validation study (September 2026) found its brain flow metric tracked ultrasound blood-flow readings with a median correlation of about 0.8 in 20 adults. The company says it cannot measure absolute blood flow. Inc42
  • Pre-orders for the first batch opened on 1 November 2026. Goyal has said he left his Eternal CEO post on 1 February 2026 to focus on Temple. MoneycontrolMoneycontrol
  • In November 2026 the device was priced at Rs 85,000, and several doctors questioned whether it can measure brain blood flow; Goyal replied that it is a fitness gadget, not medical equipment (card report; the page was blocked). Business Standard

Deals and partnerships

Temple deals and partnerships, as announced
WhenWithWhatPriceSource
Aug 2026LongevousLondon longevity medicine practiceUndisclosed Entrackr

Products

  • Temple wearable: Worn beside the forehead; tracks brain blood flow and an Entropy score. First units were due to ship before the end of 2026. EntrackrMoneycontrol

People

  • Deepinder Goyal: Founder; former Zomato (Eternal) CEO EntrackrMoneycontrol
  • Robert Mohr: Chief Medical Officer; co-founded Longevous Entrackr
  • Avi Roy: Head of Science; co-founded Longevous Entrackr

Questions people ask about Temple

What is the Temple device?

Temple is a wearable from Zomato founder Deepinder Goyal. It is worn beside the forehead and tracks signals tied to blood flow in the brain, shown as a score called Entropy from 1 to 250. The company says it is for general wellness, not medical diagnosis. EntrackrMoneycontrol

What is Temple's valuation?

Temple was valued at about $375 million in July 2026, nearly double the roughly $190 million set in its February 2026 seed round, after a secondary share sale tied to an employee stock programme. A separate report said it was seeking about $500 million. EntrackrStartupTalky

How much has Temple raised?

Temple raised $54 million (₹493 crore) in February 2026 at about $190 million post-money. Deepinder Goyal put in about ₹104 crore. Steadview Capital, Peak XV Partners, Dharana Capital and Info Edge also invested, along with dozens of other investors, including employees. EntrackrEntrackr

Does the Temple head device work?

Temple's first study, published as a preprint in September 2026 on 20 analysed adults, found its brain flow metric moved with ultrasound blood-flow readings, with a median correlation of about 0.8. The company says it does not measure absolute blood flow or diagnose conditions. Inc42

Every line links to the article it came from, written in our own words. Not investment advice. Profile updated 2026-11-15.

Stories cover its news, people, launch, partnership and acquisition. Sectors: Healthcare & Life Sciences and AI & Deep Tech. Stages: Seed, Early-access, Friends-and-family and Pre-Series A. Based in Bengaluru. Stories run from 17 January 2026 to 10 November 2026.

The founders

Deepinder Goyal

Co-founder
in
  • Founder of Eternal, the parent of Zomato

Robert Mohr

Co-founder
in

Who put in money

Every story on Temple

For Temple: add the “Featured on StopDown” badge

Put this on your website's press or media page. It links readers to Temple on StopDown.

Featured on StopDownFeatured on StopDown, dark

· About the badge